On the topic of targeting ER stress downstream signaling pathways, thioredoxin-1 was found to alleviate diabetic encephalopathy by reducing ER-stress-induced apoptosis through inhibiting apoptosis signal-regulating kinase 1 phosphorylation and decreasing JNK and caspase-12 expression. This evidence concerns the gene MAPK8 and diabetic encephalopathy.